Financials

  • Market Capitalization 706.54 M
  • Employee 106
  • Founded 2016
  • CEO N/A
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG01L3GYF02
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.02
ratio cours/chiffre d'affaires
0.18

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2677
AURA
Aura Biosciences, Inc. - Common Stock
7.00 USD0.00%-0.43%+9.03%+6.71%723.71 M USD
2679
CADL
Candel Therapeutics, Inc. - Common Stock
9.87 USD+2.39%+2.49%+16.39%+55.92%723.18 M USD
2723
MNPR
Monopar Therapeutics Inc. - Common Stock
99.79 USD-3.43%+6.31%+64.64%+82.70%668.50 M USD
2737
TECX
Tectonic Therapeutic, Inc. - Common Stock
34.81 USD+1.37%-4.13%+17.96%+102.97%656.84 M USD